Anticholinergic Toxicity


Article Author:
Erin Broderick


Article Editor:
Brianna Crosby


Editors In Chief:
Stephen Leslie
Karim Hamawy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
12/1/2018 11:26:32 PM

Introduction

Anticholinergic toxicity is common in the emergency department but rarely fatal.[1] According to the 2015 annual American Association of Poison Control Centers (AAPCC) report, there were just under 14,000 exposures reported to poison control centers that year, none of which were fatal.[1] However, in prior years, up to 51 cases have been reported as fatal.[2][3][4] Overdoses of compounds with anticholinergic activity can be accidental or intentional. This is an important topic as anticholinergics are readily accessible, and many medications have anticholinergic side-effects. Medications with anticholinergic properties are used in the treatment of motion sickness, nausea, insomnia, parkinsonism, and allergic reactions.

Etiology

Anticholinergic toxicity is typically secondary to an overdose of anticholinergic agents, although mild toxicity can be seen in the form of medication side effects. Substances with anticholinergic activity are used and misused extensively worldwide. The vast majority of these agents are orally ingested. The naturally occurring compounds atropine, hyoscyamine, and scopolamine are the prototypical anticholinergics from which others are synthesized. The prototypical anticholinergic agent atropine is used as an antidote for cholinergic toxicity from organophosphates and nerve agents.[5] Atropine is also used as an acute treatment for bradyarrhythmias.[6]

Other therapeutic uses of anticholinergics include antihistamines, antiparkinson drugs, sleep aids, antiemetics, and drugs for overactive bladder. Still, other medications have unrelated primary actions but also have anticholinergic side effects. These include tricyclic antidepressants, muscle relaxants, and antipsychotics. The effects of multiple anticholinergic medications are synergistic. This is especially important for elderly patients on multiple medications.[7][8] The most common source of an anticholinergic drug overdose is antihistamines.[1]

Plants are also a common source of accidental and intentional anticholinergic ingestion.[9] Plants that contain belladonna alkaloids are often abused due to their hallucinogenic properties.[10] Illicit drugs including cocaine and heroin have been known to be contaminated with anticholinergics such as scopolamine or atropine.[11][12][13] Toxicity has been reported with topical application.[14][15]

Epidemiology

As mentioned above, according to the AAPCC 2015 annual report, there were nearly 14,000 anticholinergic exposures reported to poison control centers.[1] The following year, there were 2,159,032 total cases of human exposure reported to poison control centers. Antihistamines were the sixth most frequently involved category of substances involved in human exposure at 4.19%.[16] These figures probably grossly underestimate the total number of exposures as many go unreported to poison control centers.

Pathophysiology

Anticholinergic agents competitively inhibit acetylcholine at muscarinic receptors. They would be more accurately described as antimuscarinic agents as they only act on muscarinic receptors. Anticholinergics do not affect nicotinic receptors. Muscarinic acetylcholine receptors are located in smooth muscle, the ciliary body of the eye, salivary glands, sweat glands, and in the central nervous system (CNS). Muscarinic receptors are not found at the neuromuscular junction.[17][18][19]

Toxicokinetics

Most anticholinergic agents are orally ingested. The onset of action of orally ingested compounds is within 2 hours.[20] The pharmacological actions of scopolamine can last for over 24 hours.[21] The cardiovascular effects have been found to be of a much shorter duration than central nervous system (CNS) effects, which can last over 8 hours.[22]

History and Physical

A thorough history and physical exam are critical to the identification of patients with anticholinergic poisoning. Patients may present with a history of intentional ingestion of common anticholinergic agents such as antihistamines or jimson weed.[9] Often, the history is less straightforward. Patients may present after a suicide attempt and be unwilling or unable to disclose what they ingested. Young children may be brought in by a caretaker/parent with somnolence or other anticholinergic symptoms although the ingestion may have been unwitnessed by the caretaker. Any history of potential co-ingestion should be obtained.

Due to potential difficulty in obtaining a reliable history, it is critical that the clinician be familiar with the anticholinergic toxidrome. The memory aid “red as a beet, dry as a bone, blind as a bat, mad as a hatter, hot as a hare, full as a flask” is helpful to remember the classic signs and symptoms of anticholinergic poisoning which include flushing, anhydrosis, dry mucous membranes, mydriasis, altered mental status, fever, and urinary retention. Decreased bowel sounds are also a common physical exam finding. CNS effects may include delirium, hallucinations, agitation, restlessness, confusion, staccato speech, and picking at clothing and bedding. Seizures and jerking movements are possible.[23][24] Diphenhydramine, in particular, has been reported to be associated with wide-complex tachycardia and QT prolongation.[25][26]

Evaluation

The clinician should utilize a standard approach to any suspected poisoned patient. As with any potentially critically ill patient, evaluation of the patient’s airway, respiratory, and circulatory status should immediately be performed. Vital signs including temperature, heart rate, respiratory rate, blood pressure, and oxygen saturation should be obtained. The patient should be fully exposed to assess for topical sources of toxicity, such as a scopolamine patch. The patient should also be placed on continuous cardiac monitoring and have intravenous (IV) access established. 

Diagnostics including urinalysis, urine drug screen, finger-stick glucose, salicylate and acetaminophen level, electrocardiogram, and pregnancy test for females should be obtained. If seizures or significant hyperthermia is present, the clinician should obtain further laboratory evaluation including a metabolic panel, liver enzymes, and creatine kinase. However, it is important to understand that anticholinergic toxicity is a clinical diagnosis. Anticholinergic toxicity can be confused with sympathomimetic toxicity. However, the absence of sweating indicates anticholinergic toxicity.[23]

Treatment / Management

Supportive care is usually all that is required for treatment of anticholinergic toxicity. However, physostigmine may be indicated in severe cases.[27] Benzodiazepines should be administered for seizure activity. IV fluids should be administered in the case of hypotension or if rhabdomyolysis is suspected. Cooling measures should be initiated if significant hyperthermia is present.[28] Activated charcoal should be considered if the ingestion was within one hour prior to presentation. However, administration somewhat outside this window may be appropriate, as anticholinergics decrease gastrointestinal motility.[29][30] If wide-complex dysrhythmias develop, IV sodium bicarbonate should be administered.[26][31]

Physostigmine is usually only given in the case of both peripheral and central signs and symptoms of anticholinergic poisoning.[27] Physostigmine is an acetylcholinesterase inhibitor active in both the central and peripheral nervous systems. Resuscitation equipment including atropine should be readily available before physostigmine is given. The recommended dose is 0.5- to 2-mg IV for adults and 0.02 mg/kg IV for pediatric patients with a maximum pediatric dose of 0.5 mg.[32] Repeat dosing may be required after approximately 30 minutes if symptoms recur.[33] In general, physostigmine is only recommended in pure anticholinergic poisoning.[34] Intravenous fat emulsion has been reported as a successful treatment for severe diphenhydramine overdose refractory to other interventions.[35]

Differential Diagnosis

Many conditions can cause agitated delirium, especially in the elderly. Side effects of other medications and polypharmacy should be considered. Meningitis, sepsis, uremia, sympathomimetic toxicity, salicylate toxicity, and serotonin syndrome can all present similarly to anticholinergic poisoning.[36] Pure anticholinergic toxicity versus mixed toxicity, as seen with tricyclic antidepressants and phenothiazines, should be considered.

Prognosis

Overall, with early identification and adequate supportive care, the prognosis of anticholinergic toxicity is good.

Complications

  • Respiratory failure
  • Cardiovascular collapse
  • Rhabdomyolysis
  • Seizures
  • Coma
  • Permanent disability
  • Death

Consultations

Depending on severity, the following consults may be indicated:

  • Poison Control can be reached 24 hours a day in the United States at 1-800-222-1222.
  • Intensivist for intensive care unit (ICU) admission
  • Psychiatry if the ingestion was intentional self-harm
  • Nephrology if dialysis is necessary

Deterrence and Patient Education

Patients taking multiple medications should be educated that anticholinergic side effects are common. Parents and guardians should be educated to keep anticholinergic medications in a safe place that is inaccessible to children. All patients should be educated not to take their medications more frequently than prescribed and not to take more than the recommended dose of over-the-counter medications. Patients should also be counseled not to drive after taking sedating anticholinergics such as antihistamines.

Pearls and Other Issues

  • Always consider anticholinergic toxicity in patients taking multiple medications, especially the elderly.
  • Always consider anticholinergic toxicity in young children who present somnolent or lethargic.
  • Remember the memory aid "red as a beet, dry as a bone, blind as a bat, mad as a hatter, hot as a hare, full as a flask."
  • Confirmatory testing is not usually readily available in the emergency setting. Anticholinergic toxicity is a clinical diagnosis.

Enhancing Healthcare Team Outcomes

The prevention and treatment of anticholinergic toxicity can be maximized by adopting a team-based approach. Psychiatry services should see any patient with anticholinergic poisoning as an inpatient and refer to outpatient behavioral health resources if the ingestion is due to intentional self-harm. Pharmacists and pharmacy technicians in the hospital and in the community are an excellent resource for education of patients and the community regarding medication side effects, dosage, and synergistic effects of taking more than one anticholinergic agent. In many emergency departments, pharmacy technicians perform routine reconciliation of patients’ home medications. Thus, pharmacy technicians have a prime opportunity to recognize and alert providers of potential drug interactions which would place a patient at higher risk for anticholinergic toxicity. Both nursing staff and pharmacy staff can play an increased role in patient education at the time of discharge from the hospital regarding the appropriate consumption of anticholinergic drugs. Nursing staff should also assist in educating all patients on anticholinergic agents on how to keep them out of reach of children. Prehospital providers can also aid clinicians in making the diagnosis of anticholinergic poisoning by interviewing bystanders and observing the scene for any medications or substances that may have been available to the patient.[37][38][39][40] (Level V)


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Anticholinergic Toxicity - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is not a symptom of acute anticholinergic overdose?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following symptoms does NOT result from anticholinergic poisoning?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which one of the following drugs can reverse the CNS side effects of anticholinergic poisoning?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following signs or symptoms are not seen with anticholinergic poisoning?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following would be the best treatment for anticholinergic crisis developing from inhalation of chemicals?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
All of the following would make you concerned about the possibility of anticholinergic ingestions except:



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following toxidromes is correct for anticholinergic toxicity?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Anticholinergic Toxicity - References

References

Mowry JB,Spyker DA,Brooks DE,Zimmerman A,Schauben JL, 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Clinical toxicology (Philadelphia, Pa.). 2016 Dec     [PubMed]
Litovitz TL,Klein-Schwartz W,Dyer KS,Shannon M,Lee S,Powers M, 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 1998 Sep     [PubMed]
Litovitz TL,Klein-Schwartz W,White S,Cobaugh DJ,Youniss J,Omslaer JC,Drab A,Benson BE, 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 2001 Sep     [PubMed]
Watson WA,Litovitz TL,Klein-Schwartz W,Rodgers GC Jr,Youniss J,Reid N,Rouse WG,Rembert RS,Borys D, 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 2004 Sep     [PubMed]
Smulyan H, The Beat Goes On: The Story of 5 Ageless Cardiac Drugs. The American journal of the medical sciences. 2018 Apr 25     [PubMed]
Geller RJ,Lopez GP,Cutler S,Lin D,Bachman GF,Gorman SE, Atropine availability as an antidote for nerve agent casualties: validated rapid reformulation of high-concentration atropine from bulk powder. Annals of emergency medicine. 2003 Apr     [PubMed]
Feinberg M, The problems of anticholinergic adverse effects in older patients. Drugs     [PubMed]
Tune LE, Anticholinergic effects of medication in elderly patients. The Journal of clinical psychiatry. 2001     [PubMed]
Vanderhoff BT,Mosser KH, Jimson weed toxicity: management of anticholinergic plant ingestion. American family physician. 1992 Aug     [PubMed]
Tiongson J,Salen P, Mass ingestion of Jimson Weed by eleven teenagers. Delaware medical journal. 1998 Nov     [PubMed]
Weiner AL,Bayer MJ,McKay CA Jr,DeMeo M,Starr E, Anticholinergic poisoning with adulterated intranasal cocaine. The American journal of emergency medicine. 1998 Sep     [PubMed]
Ridder WP,Klimek M,Rupreht J, [Physostigmine for the immediate treatment of a patient with the central anticholinergic syndrome induced by cocaine cut with atropine]. Nederlands tijdschrift voor geneeskunde. 2005 Jul 23     [PubMed]
Hamilton RJ,Perrone J,Hoffman R,Henretig FM,Karkevandian EH,Marcus S,Shih RD,Blok B,Nordenholz K, A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. Journal of toxicology. Clinical toxicology. 2000     [PubMed]
Gummin DD,Mowry JB,Spyker DA,Brooks DE,Fraser MO,Banner W, 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2017 Dec     [PubMed]
Holstege CP,Borek HA, Toxidromes. Critical care clinics. 2012 Oct     [PubMed]
Lin TJ,Nelson LS,Tsai JL,Hung DZ,Hu SC,Chan HM,Deng JF, Common toxidromes of plant poisonings in Taiwan. Clinical toxicology (Philadelphia, Pa.). 2009 Feb     [PubMed]
Thakur AC,Aslam AK,Aslam AF,Vasavada BC,Sacchi TJ,Khan IA, QT interval prolongation in diphenhydramine toxicity. International journal of cardiology. 2005 Feb 15     [PubMed]
Sharma AN,Hexdall AH,Chang EK,Nelson LS,Hoffman RS, Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. The American journal of emergency medicine. 2003 May     [PubMed]
Derinoz O,Emeksiz HC, Use of physostigmine for cyclopentolate overdose in an infant. Pediatrics. 2012 Sep     [PubMed]
Bross MH,Nash BT Jr,Carlton FB Jr, Heat emergencies. American family physician. 1994 Aug     [PubMed]
Green R,Sitar DS,Tenenbein M, Effect of anticholinergic drugs on the efficacy of activated charcoal. Journal of toxicology. Clinical toxicology. 2004     [PubMed]
Isbister GK,Kumar VV, Indications for single-dose activated charcoal administration in acute overdose. Current opinion in critical care. 2011 Aug     [PubMed]
Holger JS,Harris CR,Engebretsen KM, Physostigmine, sodium bicarbonate, or hypertonic saline to treat diphenhydramine toxicity. Veterinary and human toxicology. 2002 Feb     [PubMed]
Arens AM,Shah K,Al-Abri S,Olson KR,Kearney T, Safety and effectiveness of physostigmine: a 10-year retrospective review{sup/}. Clinical toxicology (Philadelphia, Pa.). 2018 Feb     [PubMed]
Rosenbaum C,Bird SB, Timing and frequency of physostigmine redosing for antimuscarinic toxicity. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2010 Dec     [PubMed]
Pentel P,Peterson CD, Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Annals of emergency medicine. 1980 Nov     [PubMed]
Abdelmalek D,Schwarz ES,Sampson C,Halcomb SE,McCammon C,Arroyo-Plasencia A,Stenger A,Krehbiel N,Mullins ME, Life-threatening diphenhydramine toxicity presenting with seizures and a wide complex tachycardia improved with intravenous fat emulsion. American journal of therapeutics. 2014 Nov-Dec     [PubMed]
Mitchelson F, Muscarinic receptor agonists and antagonists: effects on ocular function. Handbook of experimental pharmacology. 2012     [PubMed]
Harvey RD, Muscarinic receptor agonists and antagonists: effects on cardiovascular function. Handbook of experimental pharmacology. 2012     [PubMed]
Ehlert FJ,Pak KJ,Griffin MT, Muscarinic agonists and antagonists: effects on gastrointestinal function. Handbook of experimental pharmacology. 2012     [PubMed]
Scavone JM,Greenblatt DJ,Harmatz JS,Engelhardt N,Shader RI, Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers. Journal of clinical pharmacology. 1998 Jul     [PubMed]
Reilly JF Jr,Weisse ME, Topically induced diphenhydramine toxicity. The Journal of emergency medicine. 1990 Jan-Feb     [PubMed]
Bernhardt DT, Topical diphenhydramine toxicity. Wisconsin medical journal. 1991 Aug     [PubMed]
Renner UD,Oertel R,Kirch W, Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Therapeutic drug monitoring. 2005 Oct     [PubMed]
Ali-Melkkilä T,Kanto J,Iisalo E, Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta anaesthesiologica Scandinavica. 1993 Oct     [PubMed]
Perrone J,Chu J,Stecker MM, Viral encephalitis masquerading as a fulminant anticholinergic toxidrome. Journal of toxicology. Clinical toxicology. 1997     [PubMed]
Thomas A,Nallur DG,Jones N,Deslandes PN, Diphenhydramine abuse and detoxification: a brief review and case report. Journal of psychopharmacology (Oxford, England). 2009 Jan     [PubMed]
Grande G,Tramacere I,Vetrano DL,Clerici F,Pomati S,Mariani C,Filippini G, Role of anticholinergic burden in primary care patients with first cognitive complaints. European journal of neurology. 2017 Jul     [PubMed]
Balling L,Erstad BL,Weibel K, Impact of a transition-of-care pharmacist during hospital discharge. Journal of the American Pharmacists Association : JAPhA. 2015 Jul-Aug     [PubMed]
Borowy CS,Mukherji P, Antihistamine Toxicity null. 2018 Jan     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.